John McGuire, Republican representing Virginia's 5th district, is on Google News today for one specific reason: he's been out front carrying the administration's case for deep cuts to Medicaid and food assistance, and constituents have started asking an uncomfortable question. McGuire was self-employed when he suffered a nearly-fatal trampoline injury. He won't say how he paid for his healthcare during that period. He's now voting to make it harder for other people to get it. That's the story people are sharing. Here's what Blind Trust knows about everything else he's been doing.
The News Peg
Social commentary circulating this week centers on a series of interviews McGuire gave in support of a bill that would restrict access to food and healthcare assistance. The congressman's stated position: the bill weeds out people who shouldn't be getting help. The uncomfortable biographical footnote, per posts circulating on Bluesky: McGuire himself was self-employed at the time of a serious injury and has declined to explain how he navigated healthcare costs during his own recovery. He's not required to answer. The voters of VA-5 are not required to find that satisfying.
That's the political story. But McGuire has also filed four stock trades in the last 90 days, sits on committees with direct oversight over financial services and technology, and carries a 90-day trading record with a few numbers worth reading slowly.
The Four Trades
Per disclosure filings, McGuire's recent activity looks like this:
- July 7, 2026: Sold BlackRock ($BLK), $1,001 to $15,000.
- June 15, 2026: Bought SPCX (a space-focused ETF), $1,001 to $15,000.
- June 4, 2026: Sold Dell Technologies ($DELL), $1,001 to $15,000.
- June 4, 2026: Bought Meta Platforms ($META), $1,001 to $15,000.
All four trades sit in the minimum disclosure band. McGuire is not required to be more specific than that. Members are required to disclose. They are not required to divest, recuse, abstain, blush, or look up from their phones.
The BlackRock sale is the one that earns a second look. McGuire sits on the House Committee on Oversight and Government Reform's Health Care and Financial Services subcommittee. BlackRock is an asset management firm with extensive exposure to financial regulation. The sale cleared July 7. Blind Trust's alpha tracking puts that trade at plus-1.0% excess return over the S&P 500 in the 30 days following. Not a windfall. But it's a trade in a financial-sector stock by a member who oversees financial services, and that's the kind of overlap this publication exists to flag.
The SPCX purchase, meanwhile, aged poorly. Bought June 15. The 30-day alpha on that one: negative 13.1%. McGuire bought into a space ETF at what turned out to be an uncomfortable moment for the sector. That's just a bad trade.
The Broader Alpha Record
Zoom out past the last 90 days and the picture gets more complete, which is to say less flattering.
Across 16 scored trades in Blind Trust's database, McGuire is 6 for 16. Six trades outperformed the S&P 500 over the following 30 days. Ten did not. His mean 30-day alpha across all scored trades: negative 2.6%. That's the full record, not a cherry-picked sample. The man is, statistically, costing himself money relative to just buying an index fund and leaving it alone.
His best-performing trades were purchases of Nvidia ($NVDA) on April 15, 2026, and Microsoft ($MSFT) on January 21, 2026, generating 30-day alphas of plus-7.5% and plus-7.0% respectively. Both are technology stocks. McGuire sits on the Armed Services subcommittee covering cyber and information technologies, and on the Oversight subcommittee covering cybersecurity and government innovation. Those committee assignments give him a direct line to technology policy debates that affect both companies. That's the COI angle. Whether it means anything is a question Blind Trust leaves open.
His worst trade on record: a purchase of UnitedHealth Group ($UNH) on April 10, 2025, down 24.0% on a 30-day alpha basis. McGuire's Oversight subcommittee covers health care. He bought UNH. It fell. Hard. The universe is sometimes ironic.
The full five committee-overlap trades Blind Trust has scored break down like this: three tech purchases (Nvidia, Microsoft twice, Apple) that all came in positive, and one BlackRock sale that came in positive by a hair. The tech trades averaged roughly plus-6% alpha. The record on those specific trades looks better than his overall average, which is the kind of thing a reader will weigh as they see fit.
The Votes
McGuire has been active on the floor this session. A few votes worth noting alongside his financial record:
On June 25, he voted Yea on the Financial Exploitation Prevention Act of 2025, which passed. His Oversight subcommittee covers financial services. He holds, or recently sold, positions in financial-sector stocks. The vote and the holdings don't create a conflict on their own. Together they create a pattern worth a raised eyebrow.
On July 14, he voted Yea on the Protecting Privacy in Purchases Act (H.R. 1181), which passed. That bill touches consumer financial data, an area with direct relevance to companies like Meta, which McGuire purchased on June 4. His Oversight subcommittee on cybersecurity and information technology has jurisdiction over exactly this kind of consumer data legislation. The purchase was six weeks before the vote. The bill passed. Blind Trust is not drawing a line between those two facts. The two facts are simply in the same sentence now.
He also voted Yea on June 29 for the TRIA Program Reauthorization Act (H.R. 7128), the terrorism risk insurance backstop that the insurance and financial services industry watches closely. Passed. His portfolio at the time included financial sector exposure. Floor votes don't automatically carry a committee COI angle, and TRIA is not squarely in McGuire's subcommittee remit. Noted and set aside.
The FISA extension vote on June 11 (H.R. 9238) is the outlier: McGuire voted Yea. It failed. His committee assignments include cyber and intelligence-adjacent oversight. This is one of the relatively rare cases where McGuire voted for something that didn't make it. The market relevance there's indirect at best, but given his tech holdings, a surveillance reauthorization vote from a member holding Nvidia and Microsoft is worth putting in the record.
The Bigger Picture
McGuire is trending because of a healthcare story, not a trading story. The two threads don't connect in any direct way. He's a congressman who vocally supports benefit cuts, has a biographical inconvenience in his past that makes that position awkward to defend, and separately has a stock portfolio that would be unremarkable if not for his committee assignments and a mean alpha of negative 2.6%.
The portfolio is small-scale by congressional standards. Every trade lands in the $1,001 to $15,000 band. Nobody's getting rich here. But the pattern of technology trades from a member sitting on cyber and IT oversight subcommittees, generating above-average returns on exactly those names, is the part that earns its place in this publication.
Six wins out of sixteen trades. Negative average alpha. One space ETF that immediately went south. One BlackRock sale that landed in a financial-services oversight member's filing. Two tech purchases that outperformed by 7-plus points from a member with technology oversight jurisdiction.
That's the financial record. The healthcare story is a separate thing. McGuire and his constituents will sort out what they make of the second one. The receipts on the first are public. Make of them what you make of them.